Effect of felodipine on blood pressure and vascular reactivity in stroke-prone spontaneously hypertensive rats

Cathy A. Bruner, R. Clinton Webb

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Isolated tall arteries from stroke-prone spontaneously hypertensive rats (SHRSP), but not from normotensive Wistar-Kyoto rats (WKY), exhibit oscillatory contractions in response to norepinephrine. Previous studies indicate that the mechanism for these oscillations involves altered membrane calcium and/or potassium handling, and that this vascular change is a genetic defect associated with hypertension in SHRSP. The purpose of this experiment was to determine whether treatment of SHRSP with the calcium entry blocker felodipine would alter oscillatory activity. Adult SHRSP and WKY rats were treated orally with felodipine for 8 weeks. Felodipine treatment produced a significant decrease in blood pressure in SHRSP (control SHRSP: 240 ± 7 mmHg, n = 6; felodiplne-treated SHRSP: 164 ± 8 mmHg, n = 5, P < 0.05; tall-cuff method). Helically-cut tail artery strips from all rats were mounted in tissue baths for isometric force recording and exposed to norepinephrine (6 × 10-9 to 6 × 10-6mol/l) for 20min at each concentration. Oscillatory activity was defined as the sum of the magnitudes of all phasic contractions occurring during the final 10min of norepinephrine incubation. Oscillatory activity was markedly reduced in tail arteries from felodipine-treated SHRSP when compared with control SHRSP. Felodipine also inhibited oscillatory activity when added directly to the tissue bath. It seems, therefore, that felodipine may lower blood pressure in SHRSP, at least in part, by correcting the genetic defect responsible for oscillatory activity.

Original languageEnglish (US)
Pages (from-to)31-35
Number of pages5
JournalJournal of hypertension
Volume7
Issue number1
DOIs
StatePublished - Jan 1989

Fingerprint

Felodipine
Inbred SHR Rats
Blood Vessels
Stroke
Blood Pressure
Norepinephrine
Inbred WKY Rats
Arteries
Baths
Tail
Calcium
Potassium
Hypertension
Membranes
Therapeutics

Keywords

  • Calcium entry blockers
  • Genetic hypertension
  • Norepinephrine
  • Oscillations
  • Tail artery

ASJC Scopus subject areas

  • Internal Medicine
  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Effect of felodipine on blood pressure and vascular reactivity in stroke-prone spontaneously hypertensive rats. / Bruner, Cathy A.; Clinton Webb, R.

In: Journal of hypertension, Vol. 7, No. 1, 01.1989, p. 31-35.

Research output: Contribution to journalArticle

@article{e809716791f84d579cad190ec44c9026,
title = "Effect of felodipine on blood pressure and vascular reactivity in stroke-prone spontaneously hypertensive rats",
abstract = "Isolated tall arteries from stroke-prone spontaneously hypertensive rats (SHRSP), but not from normotensive Wistar-Kyoto rats (WKY), exhibit oscillatory contractions in response to norepinephrine. Previous studies indicate that the mechanism for these oscillations involves altered membrane calcium and/or potassium handling, and that this vascular change is a genetic defect associated with hypertension in SHRSP. The purpose of this experiment was to determine whether treatment of SHRSP with the calcium entry blocker felodipine would alter oscillatory activity. Adult SHRSP and WKY rats were treated orally with felodipine for 8 weeks. Felodipine treatment produced a significant decrease in blood pressure in SHRSP (control SHRSP: 240 ± 7 mmHg, n = 6; felodiplne-treated SHRSP: 164 ± 8 mmHg, n = 5, P < 0.05; tall-cuff method). Helically-cut tail artery strips from all rats were mounted in tissue baths for isometric force recording and exposed to norepinephrine (6 × 10-9 to 6 × 10-6mol/l) for 20min at each concentration. Oscillatory activity was defined as the sum of the magnitudes of all phasic contractions occurring during the final 10min of norepinephrine incubation. Oscillatory activity was markedly reduced in tail arteries from felodipine-treated SHRSP when compared with control SHRSP. Felodipine also inhibited oscillatory activity when added directly to the tissue bath. It seems, therefore, that felodipine may lower blood pressure in SHRSP, at least in part, by correcting the genetic defect responsible for oscillatory activity.",
keywords = "Calcium entry blockers, Genetic hypertension, Norepinephrine, Oscillations, Tail artery",
author = "Bruner, {Cathy A.} and {Clinton Webb}, R.",
year = "1989",
month = "1",
doi = "10.1097/00004872-198901000-00005",
language = "English (US)",
volume = "7",
pages = "31--35",
journal = "Journal of Hypertension",
issn = "0263-6352",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Effect of felodipine on blood pressure and vascular reactivity in stroke-prone spontaneously hypertensive rats

AU - Bruner, Cathy A.

AU - Clinton Webb, R.

PY - 1989/1

Y1 - 1989/1

N2 - Isolated tall arteries from stroke-prone spontaneously hypertensive rats (SHRSP), but not from normotensive Wistar-Kyoto rats (WKY), exhibit oscillatory contractions in response to norepinephrine. Previous studies indicate that the mechanism for these oscillations involves altered membrane calcium and/or potassium handling, and that this vascular change is a genetic defect associated with hypertension in SHRSP. The purpose of this experiment was to determine whether treatment of SHRSP with the calcium entry blocker felodipine would alter oscillatory activity. Adult SHRSP and WKY rats were treated orally with felodipine for 8 weeks. Felodipine treatment produced a significant decrease in blood pressure in SHRSP (control SHRSP: 240 ± 7 mmHg, n = 6; felodiplne-treated SHRSP: 164 ± 8 mmHg, n = 5, P < 0.05; tall-cuff method). Helically-cut tail artery strips from all rats were mounted in tissue baths for isometric force recording and exposed to norepinephrine (6 × 10-9 to 6 × 10-6mol/l) for 20min at each concentration. Oscillatory activity was defined as the sum of the magnitudes of all phasic contractions occurring during the final 10min of norepinephrine incubation. Oscillatory activity was markedly reduced in tail arteries from felodipine-treated SHRSP when compared with control SHRSP. Felodipine also inhibited oscillatory activity when added directly to the tissue bath. It seems, therefore, that felodipine may lower blood pressure in SHRSP, at least in part, by correcting the genetic defect responsible for oscillatory activity.

AB - Isolated tall arteries from stroke-prone spontaneously hypertensive rats (SHRSP), but not from normotensive Wistar-Kyoto rats (WKY), exhibit oscillatory contractions in response to norepinephrine. Previous studies indicate that the mechanism for these oscillations involves altered membrane calcium and/or potassium handling, and that this vascular change is a genetic defect associated with hypertension in SHRSP. The purpose of this experiment was to determine whether treatment of SHRSP with the calcium entry blocker felodipine would alter oscillatory activity. Adult SHRSP and WKY rats were treated orally with felodipine for 8 weeks. Felodipine treatment produced a significant decrease in blood pressure in SHRSP (control SHRSP: 240 ± 7 mmHg, n = 6; felodiplne-treated SHRSP: 164 ± 8 mmHg, n = 5, P < 0.05; tall-cuff method). Helically-cut tail artery strips from all rats were mounted in tissue baths for isometric force recording and exposed to norepinephrine (6 × 10-9 to 6 × 10-6mol/l) for 20min at each concentration. Oscillatory activity was defined as the sum of the magnitudes of all phasic contractions occurring during the final 10min of norepinephrine incubation. Oscillatory activity was markedly reduced in tail arteries from felodipine-treated SHRSP when compared with control SHRSP. Felodipine also inhibited oscillatory activity when added directly to the tissue bath. It seems, therefore, that felodipine may lower blood pressure in SHRSP, at least in part, by correcting the genetic defect responsible for oscillatory activity.

KW - Calcium entry blockers

KW - Genetic hypertension

KW - Norepinephrine

KW - Oscillations

KW - Tail artery

UR - http://www.scopus.com/inward/record.url?scp=0024550674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024550674&partnerID=8YFLogxK

U2 - 10.1097/00004872-198901000-00005

DO - 10.1097/00004872-198901000-00005

M3 - Article

C2 - 2708810

AN - SCOPUS:0024550674

VL - 7

SP - 31

EP - 35

JO - Journal of Hypertension

JF - Journal of Hypertension

SN - 0263-6352

IS - 1

ER -